Yu; Hung-Man

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yu; Hung-Man.The latest application filed is for "hexa-lactoside-triazanonane triacetic acid (nota) derivative, method for radiolabeling hexa-lactoside positron emission tomograp".

Company Profile

5.10.11

Yu; Hung-Man - Taoyuan TW
Yu; Hung-Man - Taoyuan County TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hexa-lactoside-triazanonane triacetic acid (NOTA) derivative, method for radiolabeling hexa-lactoside positron emission tomography (PET) imaging agent for liver receptor with Ga-68, and hexa-lactoside PET imaging agent for liver receptor Grant 10,925,981 - Lin , et al. February 23, 2	2021-02-23
Hydroxamic acid type contrast agent containing radioisotope fluoride, preparation method and application thereof Grant 10,538,486 - Wang , et al. Ja	2020-01-21
Hexa-lactoside-triazanonane Triacetic Acid (nota) Derivative, Method For Radiolabeling Hexa-lactoside Positron Emission Tomograp App 20190343971 - Lin; Wuu-Jyh ; et al.	2019-11-14
Multivalent saccharide complex, radioactive multivalent saccharide complex contrast agent, and use thereof Grant 10,434,196 - Yu , et al. O	2019-10-08
Hydroxamic Acid Type Contrast Agent Containing Radioisotope Fluoride, Preparation Method And Application Thereof App 20190106381 - WANG; MEI-HUI ; et al.	2019-04-11
Multivalent Saccharide Complex, Radioactive Multivalent Saccharide Complex Contrast Agent, And Use Thereof App 20190091352 - Yu; Hung-Man ; et al.	2019-03-28
Bispecific peptide conjugate and radioactive bispecific peptide imaging agent Grant 9,981,050 - Yu , et al. May 29, 2	2018-05-29
Bispecific Peptide Conjugate And Radioactive Bispecific Peptide Imaging Agent App 20170095581 - YU; HUNG-MAN ; et al.	2017-04-06
Quantification method for remaining liver function and novel liver receptor imaging agent Grant 9,409,939 - Wang , et al. August 9, 2	2016-08-09
Gall bladder imaging agent and its preparation method Grant 9,226,982 - Wang , et al. January 5, 2	2016-01-05
Liver-receptor imaging injection, dispensing method and pharmaceutical composition thereof Grant 9,040,017 - Wang , et al. May 26, 2	2015-05-26
Radiolabeled Nucleoside Analogue, And Preparation Method And Use Thereof App 20140221639 - WANG; HSIN-ELL ; et al.	2014-08-07
Novel Gall Bladder Imaging Agent And Its Preparation Method App 20140186262 - WANG; MEI-HUI ; et al.	2014-07-03
Quantification Method For Remaining Liver Function And Novel Liver Receptor Imaging Agent App 20130225798 - WANG; MEI-HUI ; et al.	2013-08-29
Quantification method for remaining liver function and novel liver receptor imaging agent Grant 8,435,491 - Wang , et al. May 7, 2	2013-05-07
Radiolabeled Nucleoside Analogue, And Preparation Method And Use Thereof App 20120178919 - WANG; HSIN-ELL ; et al.	2012-07-12
Liver- Receptor Imaging Injection, Dispensing Method And Pharmaceutical Composition Thereof App 20120107236 - WANG; MEI-HUI ; et al.	2012-05-03
Radiolabeling Method Using Multivalent Glycoligands As Hepatic Receptor Imaging Agent App 20110097264 - Wang; Mei-Hui ; et al.	2011-04-28
Quantification Method For Remaining Liver Function And Novel Liver Receptor Imaging Agent App 20110097265 - Wang; Mei-Hui ; et al.	2011-04-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.